AI Generated Image
Two Conditions Newly Eligible for Treatment with Medical Cannabis
thexradio.com • • health
Key Points:
- The Illinois Department of Public Health (IDPH) has added polyendocrine metabolic ovarian syndrome (PMOS) with chronic pain and sickle cell disease to the list of conditions eligible for the Medical Cannabis Patient Program.
- The additions were approved by IDPH Director Dr. Sameer Vohra after a thorough review by the Medical Cannabis Advisory Board and consideration of scientific evidence.
- PMOS, previously known as polycystic ovary syndrome (PCOS), involves hormonal and metabolic issues that cause chronic pain, for which cannabis may provide relief.
- Sickle cell disease, characterized by severe pain and other complications due to abnormal red blood cells, is now recognized as a condition that can benefit from medical cannabis treatment.
- IDPH emphasizes the importance of expert review and current evidence in expanding access to medical cannabis for Illinois residents with debilitating conditions.
